UB Paderborn / Katalog / Suche / in CDI

Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists

Journal of rheumatology, 2010-01, Vol.37 (1), p.175

2010

Volltextzugriff (PDF)

The Approach to the Child with Joint Complaints

The Pediatric clinics of North America, 2018-08, Vol.65 (4), p.623-638

Haines, Kathleen A.

2018

Volltextzugriff (PDF)

Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma

Rheumatology (Oxford, England), 2021-12, Vol.60 (12), p.5724-5733

2021

Volltextzugriff (PDF)

Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy

Arthritis & rheumatology (Hoboken, N.J.), 2019-03, Vol.71 (3), p.451-459

2019

Volltextzugriff (PDF)

Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease

Arthritis & rheumatology (Hoboken, N.J.), 2018-09, Vol.70 (9), p.1508-1518

2018

Volltextzugriff (PDF)

Malignancy in Pediatric-onset Systemic Lupus Erythematosus

Journal of rheumatology, 2017-10, Vol.44 (10), p.1484

2017

Volltextzugriff (PDF)

Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis

Pediatric nephrology (Berlin, West), 2008-03, Vol.23 (3), p.403-412

2008

Volltextzugriff (PDF)

Juvenile idiopathic arthritis: therapies in the 21st century

Bulletin of the NYU Hospital for Joint Diseases, 2007-09, Vol.65 (3), p.205

Haines, Kathleen A

2007

Volltextzugriff (PDF)

Cancer risk in childhood-onset systemic lupus

Arthritis research & therapy, 2013-01, Vol.15 (6), p.R198-R198

2013

Volltextzugriff (PDF)

Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study

Arthritis & rheumatology (Hoboken, N.J.), 2016-10, Vol.68 (10), p.2514-2526

2016

Volltextzugriff (PDF)

A randomized study of local anesthesia for pain control during intra-articular corticosteroid injection in children with arthritis

Pediatric rheumatology online journal, 2015-08, Vol.13 (1), p.36-36, Article 36

2015

Volltextzugriff (PDF)

Consensus treatments for moderate juvenile dermatomyositis: Beyond the first two months. Results of the Second Childhood Arthritis and Rheumatology Research Alliance Consensus Conference

Arthritis care & research (2010), 2012-04, Vol.64 (4), p.546-553

2012

Volltextzugriff (PDF)

Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile‐Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature

Arthritis & rheumatology (Hoboken, N.J.), 2024-03, Vol.76 (3), p.455-468

2024

Volltextzugriff (PDF)

Immunome perturbation is present in patients with juvenile idiopathic arthritis who are in remission and will relapse upon anti-TNFα withdrawal

Annals of the rheumatic diseases, 2019-12, Vol.78 (12), p.1712

2019

Volltextzugriff (PDF)

Durability of response to intra-articular corticosteroid injections with triamcinolone hexacetonide in juvenile idiopathic arthritis

Pediatric rheumatology online journal, 2012-07, Vol.10 (S1), p.A47-A47, Article A47

2012

Volltextzugriff (PDF)

Morbidity, Mortality, and Therapeutics in Combined Immunodeficiency: Data From the USIDNET Registry

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2022-05, Vol.10 (5), p.1334-1341.e6

2022

Volltextzugriff (PDF)

Organ system-involvement in SLE and relationship with demographic factors, disease duration and health-related quality of life in childhood SLE

Pediatric rheumatology online journal, 2012-07, Vol.10 (S1), p.A22-A22, Article A22

2012

Volltextzugriff (PDF)

Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophil cytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe)

Journal of rheumatology, 2012-05, Vol.39 (5), p.1088

2012

Volltextzugriff (PDF)

Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature

Pediatric rheumatology online journal, 2015-04, Vol.13 (1), p.13-13, Article 13

2015

Volltextzugriff (PDF)

Neutrophil gelatinase–associated lipocalin is a predictor of the course of global and renal childhood‐onset systemic lupus erythematosus disease activity

Arthritis and rheumatism, 2009-09, Vol.60 (9), p.2772-2781

2009

Volltextzugriff (PDF)

Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort

Lupus, 2010-10, Vol.19 (11), p.1315-1325

2010

Volltextzugriff (PDF)

Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisions

Journal of rheumatology, 2012-10, Vol.39 (10), p.2012

2012

Volltextzugriff (PDF)

Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy

Lupus science & medicine, 2014-04, Vol.1 (1), p.e000011-e000011

2014

Volltextzugriff (PDF)

Risk, Timing and Predictors of Disease Flare after Discontinuation of Anti-Tumor Necrosis Factor (TNF) Therapy in Children with Polyarticular Forms of Juvenile Idiopathic Arthritis (JIA) in Clinical Inactive Disease

Arthritis & rheumatology (Hoboken, N.J.), 2018-07, Vol.70 (9), p.1508-1518

2018

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists

The Approach to the Child with Joint Complaints

Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions

Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma

Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy

Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease

Malignancy in Pediatric-onset Systemic Lupus Erythematosus

Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis

Juvenile idiopathic arthritis: therapies in the 21st century

Cancer risk in childhood-onset systemic lupus

Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study

A randomized study of local anesthesia for pain control during intra-articular corticosteroid injection in children with arthritis

Consensus treatments for moderate juvenile dermatomyositis: Beyond the first two months. Results of the Second Childhood Arthritis and Rheumatology Research Alliance Consensus Conference

Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile‐Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature

Immunome perturbation is present in patients with juvenile idiopathic arthritis who are in remission and will relapse upon anti-TNFα withdrawal

Durability of response to intra-articular corticosteroid injections with triamcinolone hexacetonide in juvenile idiopathic arthritis

Morbidity, Mortality, and Therapeutics in Combined Immunodeficiency: Data From the USIDNET Registry

Organ system-involvement in SLE and relationship with demographic factors, disease duration and health-related quality of life in childhood SLE

Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophil cytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe)

Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature

Neutrophil gelatinase–associated lipocalin is a predictor of the course of global and renal childhood‐onset systemic lupus erythematosus disease activity

Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort

Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisions

Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy

Risk, Timing and Predictors of Disease Flare after Discontinuation of Anti-Tumor Necrosis Factor (TNF) Therapy in Children with Polyarticular Forms of Juvenile Idiopathic Arthritis (JIA) in Clinical Inactive Disease

Suchergebnisse filtern